Company started their journey in 1983 with only five main line products but within three decades they became leading giants in pharmaceutical industry with 7000 employees, 17 manufacturing locations across globe, two R&D centers, and product presence in 30 countries. Sun pharmaceutical has grown through experience, world class products, internal growth and accruing other pharmaceutical companies. In a short and long term development and diversification plan, sun pharmaceutical had bought US-based Caraco Pharmaceutical Labs and ICN Hungary.
Sun purchased a number of brands from Natco Pharma and created a milestone in trading, with 500 million INR just in selling. The Natco brands gave the company new production options, in gastroenterology, orthopedics, pediatrics, and other categories, as well as access to Natco’s time-release technology. This accqusition spree fetched Sun seven major companies and a wide vareity of active produts.
Latest analysis report of complete product line suggest that the company offers formulations in sterile dry powder injections, small volume injections, tablets, capsules, aerosols, liposomal and depot preparations, and ointments; and specialty generics in the areas of analgesics, orthopedics, muscle relaxants, anaesthesiology, anti-asthmatics, anti-diabetics, anti-emetics, anti-infectives, anti-histamines and allergics, cardiology, gastroenterology, gynaecolog, neurology, nutritionals, oncology, ophthalmology, psychiatry, and urologicals. Producing huge revenue of 4.2 billion US dollars and net income of Rs.7.842.7 billion INR, it is the first ever Indian company to reach such growth.
Here a tip for consumers and trading companies; Sun pharma test their products through several tough quality control tests before they are put in market. Next time make sure you buy a sun pharma product. This indigenous success story is serving the traders as well who trades in the stocks of the company for both long term and short term benefits. If you intend to buy or sell stocks in the company then you can request expert tips and analysis from this platform which is always ready to help you out with successful stock trading calls.
Sell Sun Pharma at Rs 1435 with intra-day target of Rs 1414 and stop loss of Rs 1446, says Simi Bhaumik, technical analyst, on Zee Business. The stock last traded at Rs 1440.60, down 1.1 % on the BSE.